VOYA Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27K | Hold |
22,502
| – | – | ﹤0.01% | 2321 |
|
|
2025
Q4 | $22.1K | Hold |
22,502
| – | – | ﹤0.01% | 2398 |
|
|
2025
Q3 | $28.4K | Sell |
22,502
-9,637
| -30% | -$10.4K | ﹤0.01% | 2424 |
|
|
2025
Q2 | $36K | Buy |
32,139
+2,463
| +8% | +$2.86K | ﹤0.01% | 2637 |
|
|
2025
Q1 | $23.4K | Sell |
29,676
-1,583
| -5% | -$1.94K | ﹤0.01% | 2612 |
|
|
2024
Q4 | $51.6K | Sell |
31,259
-2,175
| -7% | -$5.48K | ﹤0.01% | 2680 |
|
|
2024
Q3 | $117K | Buy |
33,434
+180
| +0.5% | +$700 | ﹤0.01% | 2622 |
|
|
2024
Q2 | $109K | Buy |
33,254
+5,466
| +20% | +$23.9K | ﹤0.01% | 2643 |
|
|
2024
Q1 | $204K | Sell |
27,788
-65,525
| -70% | -$406K | ﹤0.01% | 2446 |
|
|
2023
Q4 | $349K | Buy |
93,313
+11,492
| +14% | +$27.1K | ﹤0.01% | 2266 |
|
|
2023
Q3 | $173K | Buy |
81,821
+24,625
| +43% | +$81.6K | ﹤0.01% | 2587 |
|
|
2023
Q2 | $272K | Buy |
57,196
+5,590
| +11% | +$30.9K | ﹤0.01% | 2426 |
|
|
2023
Q1 | $294K | Buy |
51,606
+19,645
| +61% | +$119K | ﹤0.01% | 2341 |
|
|
2022
Q4 | $322K | Hold |
31,961
| – | – | ﹤0.01% | 2287 |
|
|
2022
Q3 | $716K | Sell |
31,961
-1,028
| -3% | -$29.7K | ﹤0.01% | 1806 |
|
|
2022
Q2 | $817K | Sell |
32,989
-84,606
| -72% | -$2.33M | ﹤0.01% | 1539 |
|
|
2022
Q1 | $4.56M | Buy |
117,595
+85,733
| +269% | +$3.32M | 0.01% | 861 |
|
|
2021
Q4 | $1.86M | Sell |
31,862
-208,013
| -87% | -$11.8M | ﹤0.01% | 1190 |
|
|
2021
Q3 | $14.2M | Buy |
239,875
+30,588
| +15% | +$2.4M | 0.03% | 444 |
|
|
2021
Q2 | $18.2M | Sell |
209,287
-29,460
| -12% | -$2.37M | 0.04% | 382 |
|
|
2021
Q1 | $19.7M | Buy |
238,747
+37,429
| +19% | +$3.59M | 0.04% | 346 |
|
|
2020
Q4 | $18.3M | Buy |
201,318
+173,870
| +633% | +$10.8M | 0.04% | 373 |
|
|
2020
Q3 | $1.1M | Buy |
27,448
+5,762
| +27% | +$201K | ﹤0.01% | 1247 |
|
|
2020
Q2 | $744K | Sell |
21,686
-8,488
| -28% | -$253K | ﹤0.01% | 1422 |
|
|
2020
Q1 | $670K | Buy |
30,174
+655
| +2% | +$16.6K | ﹤0.01% | 1447 |
|
|
2019
Q4 | $578K | Buy |
29,519
+7,779
| +36% | +$124K | ﹤0.01% | 1811 |
|
|
2019
Q3 | $338K | Sell |
21,740
-2,698
| -11% | -$51.7K | ﹤0.01% | 1977 |
|
|
2019
Q2 | $496K | Sell |
24,438
-674
| -3% | -$12.1K | ﹤0.01% | 1784 |
|
|
2019
Q1 | $441K | Hold |
25,112
| – | – | ﹤0.01% | 1849 |
|
|
2018
Q4 | $322K | Buy |
25,112
+4,762
| +23% | +$66.4K | ﹤0.01% | 1982 |
|
|
2018
Q3 | $332K | Hold |
20,350
| – | – | ﹤0.01% | 2089 |
|
|
2018
Q2 | $231K | Hold |
20,350
| – | – | ﹤0.01% | 2292 |
|
|
2018
Q1 | $199K | Sell |
20,350
-1,183
| -5% | -$11.3K | ﹤0.01% | 2321 |
|
|
2017
Q4 | $132K | Hold |
21,533
| – | – | ﹤0.01% | 2450 |
|
|
2017
Q3 | $85K | Buy |
+21,533
| New | +$73.2K | ﹤0.01% | 2579 |
|
Other funds holding FATE
RG
VCM
VPM
JJ
VOYA Investment Management's FATE Position: Q1 2026 in Review
VOYA Investment Management held its Fate Therapeutics (FATE) position steady in Q1 2026 at 22,502 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.
VOYA Investment Management first reported a position in FATE in Q3 2017 and has held it in 35 quarters since. The position peaked at $19.7M in Q1 2021. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.
- VOYA Investment Management held 22,502 shares of Fate Therapeutics worth $27K as of Q1 2026.
- VOYA Investment Management left its Fate Therapeutics share count unchanged in Q1 2026.
- Fate Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2321 holding.
- VOYA Investment Management first reported a position in Fate Therapeutics in Q3 2017 and has held it in 35 quarters since.
- VOYA Investment Management's Fate Therapeutics position peaked at $19.7M in Q1 2021.
- 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.